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Abstract
Objectives. Groove pancreatitis (GP) describes a form of segmental pancreatitis, which affects the pancreatic head at the
interface with the duodenum, and is frequently associated with ectopic pancreatic tissue in the duodenal wall. We present a
series of symptomatic patients with complicated GP who underwent pancreaticoduodenectomy, and review the diagnostic
challenges, imaging modalities, pathological features and clinical outcome of this rare condition. Patients and methods. This
was a prospective case base study of clinical, radiological and pathological data collected between the years 2000 and 2005
on patients diagnosed with severe GP  confirmed by histopathological examination following pancreaticoduodenectomy.
Results. In total 11 patients were included, presenting with chronic abdominal pain (n11), gastric outlet obstruction (n
5) and jaundice (n1). Exocrine dysfunction with associated weight loss (median9 kg) was present in 10 patients, and
type 2 diabetes in 2 patients. Radiological imaging (CT/MRCP/EUS) provided complementary investigations and
correlated well with classic histopathological findings (duodenal wall thickening, mucosal irregularity and Brunner’s gland
hyperplasia, duodenal wall cysts and pancreatic heterotropia). Following pancreaticoduodenectomy (median follow-up
period 52 weeks) all patients experienced significant pain alleviation and weight gain (average 3 kg at 2 months). Conclusion.
Pancreaticoduodenectomy is associated with significant improvements in weight gain and alleviates the chronic pain
associated with severe GP.
Introduction
A distinct form of chronic pancreatitis occurring
predominantly in and around the duodenal wall has
been reported under various names, including cystic
dystrophy of heterotopic pancreas [1], pancreatic
hamartoma of duodenum [2], para-duodenal wall
cyst, myoadenomatosis [3] and groove pancreatitis
(GP) [4]. The underlying pathology involves inflam-
matory changes of the duodenal wall resulting in
thickening and cyst formation, as first described by
Potet and Duclert [1]. The term groove pancreatitis
was coined by Becker [4] to describe a form of
segmental pancreatitis, which affects the pancreatic
head at the interface with the duodenum, and is
frequently associated with ectopic pancreatic tissue in
the duodenal wall. This rare but distinct entity is often
confused clinically with ampullary neoplasms, duode-
nal tumours, cystic tumours of the head of pancreas
and acute relapsing pancreatitis. Patients with GP have
duodenal stenosis with a clinical pattern similar to
chronic pancreatitis (CP), although CP is often asso-
ciated with the disease itself [2,57]. Clinical compli-
cations associated with GP are related to inflammatory
changes affecting the duodenal wall, these include
major gastrointestinal haemorrhage, perforation,
chronic debilitating abdominal pain, recurrent pan-
creatitis, duodenal stenosis, and albeit a small risk of
malignant transformation of ectopic pancreas [59].
We present a series of symptomatic patients with
GP who underwent pancreaticoduodenectomy, and
review the diagnostic challenges, imaging modalities,
pathological features and clinical outcome of this rare
condition.
Patients and methods
Patients undergoing pancreaticoduodenectomy (PD)
for symptomatic GP following a clinical diagnosis of
GP supported by radiological imaging that included
computed tomography (CT), magnetic resonance
imaging (MRI), magnetic resonance cholangiopan-
creatography (MRCP), endoscopic retrograde cho-
langiopancreatography (ERCP) and trans-duodenal
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endoscopic ultrasonography (EUS) were prospec-
tively included in the study at the Leeds Teaching
Hospitals NHS Trust during a 6-year period (2000
2005). GP was confirmed histologically in all cases
following pancreaticoduodenectomy by a specialist
pancreatic histopathologist (C.V.). Collated data in-
cluded demography, clinical presentation, disease
complications, diagnostic work-up (tumour markers,
liver function tests and endoscopic/radiological inves-
tigations) and clinical outcome (treatment, morbidity
and mortality).
Results
Eleven patients were included in the study (10 men
and 1 woman), with a median age at diagnosis of 48
years (range 3561 years) (Table I). All patients had
chronic abdominal pain requiring a minimum of
regular non-opiate analgesia. Pain was often described
as a dull epigastric pain radiating to the back. Nine of
11 patients were on regular opiate analgesia, 2 of
whom were also taking tricyclic antidepressants. Five
patients were under regular review by the chronic pain
team. Intermittent nausea and vomiting occurring for
more than 2 months was featured in eight patients
(73%). An acute presentation of gastric outflow
obstruction occurred in five patients, four of whom
could not tolerate solids or liquids. One patient
presented with jaundice.
The majority of patients were heavy alcohol drin-
kers with an average weekly intake30 units per week
(range 2050 units) (Table I). All but one patient
were heavy smokers ( 25 pack years). Eight patients
had a history of recurrent attacks of pancreatitis, with
a median number of three attacks (range 15) over
the last 3 years (Table I).
Evidence of exocrine insufficiency was present in 10
of 11 patients, manifest as steatorrhoea in 4 patients
(36%), and significant weight loss in 10 patients
(mean weight loss of 9 kg in 3 months, range 064
kg). Only two patients (18%) were diabetics, report-
ing increased insulin requirements prior to diagnosis.
Derangements in liver function tests were detected
in three patients (one had an isolated elevation in
alanine-L-transpeptidase (ALT), one had an isolated
elevation in alkaline phosphatase (AlkPhos) and one
had elevated ALT, AlkPhos and bilirubin (TBil 76 IU/
L) and was clinically jaundiced at presentation.
Mild hyperamylasaemia was detected in two pa-
tients (serum amylase of 408 and 421 IU/L), and
both these patients had normal liver function tests
(Table I). Serum CEA and CA 19.9 levels were within
normal range in all patients where measured.
Diagnostic imaging
Nine of 11 patients underwent a contrast-enhanced
multi-slice CT scan of the abdomen with particular
emphasis on the pancreas and duodenum (Table II).
Features diagnostic of GP on CT were present in six
patients (67%). Cystic lesions in the head of pancreas
at the interface with the duodenum were observed in
four cases, although a mass, either cystic or solid, was
observed in five patients. Duodenal wall thickening
with or without cystic changes was reported in five
patients, and calcification of the pancreatic parench-
yma was present in only two cases (18%). Following
CT scan, four patients went on to have MRI/MRCP
as their next investigation (of which three required
EUS). A further four patients underwent EUS alone.
MRI/MRCP was carried out in six patients (follow-
ing CT in four patients, and as a primary modality
following ultrasound scan in two patients). Cystic
changes in the duodenal wall were confirmed in three
patients as reported on CT imaging. One patient was
reported to have a complex mass, and two patients
had inflammatory changes at the pancreaticoduodenal
groove (Table II). Isolated biliary dilatation was
observed in two patients (one with cystic changes in
the duodenal wall and the other with a mass in the
head of pancreas), and dilatation of both common bile
duct (CBD) and pancreatic duct (PD) was seen in
two further cases (one with a cystic mass of the head
of pancreas and the other with an ill-defined lesion at
the distal end of the CBD). Isolated PD dilatation was
Table I. Baseline patient demographics, pancreatic functional status and blood biochemistry.
Case Age Dx Abdominal pain Weight loss Pancreatitis Steatorrhoea Diabetes Alcohol Smoking GOO Analgesia
1 51 Y Y N N N Y Y Y NSAIDS, opiates
2 42 Y Y N N N Y Y Y NSAIDS, opiates
3 35 Y Y Y; 5 Y Y Y Y Y NSAIDS, opiates
4 46 Y Y Y; 4 Y N Y Y N NSAIDS, opiates
5 52 Y Y Y; 4 Y N Y Y N NSAIDS, opiates
6 49 Y N N N N Y Y N NSAIDS
7 48 Y Y Y; 2 N N Y Y Y NSAIDS, opiates
8 57 Y Y Y; 2 N Y Y N Y NSAIDS
9 47 Y Y Y; 3 N N Y Y N NSAIDS, opiates
10 39 Y Y Y; 3 N N Y Y N NSAIDS, opiates
11 61 Y Y Y; 1 Y N Y Y N NSAIDS, opiates
GOO, gastric outlet obstruction; NSAIDs, non-steroidal anti-inflammatory drugs; Y, yes; N, no.
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Table II. Radiological and histopathologically determined characteristics of groove pancreatitis.
Histopathology
No. CT MRCP EUS
Suspected
diagnosis Microscopy No. of cysts Special features
Distance into
HOP (cm) Diagnosis
1 4 cm MHOP, BDD,
PDD
Not done CP Pancreatic
cancer
GF, BGH, EP, antral gastritis Multiple Max. size
0.2 cm
Necrosis B1 mm
to PD
1.5 Pure GP
2 4 cm CMHOP CCDW, BDD DS, CCDW GP CCDW (3), EP, BGH, GF 3 Max. size 1.5 cm  1.5 Pure GP
3 2 cm CMHOPNot
done
Not done Cystic tumour CCDW, GF,
EP, CPHOP
Multiple Max. size 1.8 cm  NA Segmental GP
4 DWT, CCDW Not done CP, SHOP, DWT,
BDD, PDD
GP BDD, PDD, CCDW, GF, EP,
BGH
15 Max. size 0.3 cm Rupture of
Santorini duct
0.8 Pure GP
5 DWT, CP, CCDW Not done CP, DS, DWT,
BDD, PDD
GP CCDW, GF, EP, BGH, CPHOP 2 Max. size 1.5 cm  1.2 Segmental GP
6 Not done MHOP, BDD DPDD, CMHOP Cystic tumour CCDW, EP, GF Multiple Max. size
1.1 cm
Ruptured
Santorini duct
2.5 Pure GP
7 DWT, DS, CDDW,
CP
DWT, CCDW Not done GP CCDW, GF, BGH, CPHOP,
antral gastritis
Multiple Max. size
1.0 cm
 1 Segmental GP
8 Not done 5 cm
CMHOPDWT
CCDW, DS GP CCDW, EP, BGH, DS, antral
gastritis
3 Max. size 2.0 cm  0.7 Pure GP
9 DWT, BDD BDD, PDD CP, BDD, PDD Ampullary
tumour
CCDW, GF, BGH, EP Multiple Max. size
1.0 cm
 1.3 Pure GP
10 CMHOPDWT Not done DWT, CCDWCP GP CCDW, GF, BGH, EP Multiple Max. size
0.2 cm
 0.8 Pure GP
11 3 cm CMHOP 1.5 cm MHOP,
BDD, PDD
1.3 cm CMHOP,
BDD, CP
Pancreatic
cancer
GF, BGH, EP 1 Max. size 0.5 cm  0.5 Pure GP
CT, computed tomography; MRCP, magnetic resonance cholangiopancreatogram; EUS, endoscopic ultrasound; HOP, head of pancreas; MHOP, mass head of pancreas; BDD, biliary duct dilatation;
CMHOP, cystic mass head of pancreas; SHOP, swollen head of pancreas; DWT, duodenal wall thickening; CCDW, cystic changes duodenal wall; CP, chronic pancreatitis; CPHOP, chronic pancreatitis
head of pancreas; DS, duodenal stenosis; PDD, pancreatic duct dilatation; DPDD, distal pancreatic duct dilatation; GP, groove pancreatitis; GF, groove fibrosis and scarring; BGH, Brunners’ gland
hyperplasia (duodenum); EP, ectopic pancreatic tissue.
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not observed in any of the cases. MRI observations
correlated well with CT findings (all four patients),
and provided additional information with respect to
PD dilatation in a patient reported to have only biliary
dilatation on CT. In the two patients who had an MRI
as first line imaging, one was shown to have a complex
mass in the pancreaticoduodenal groove and the
second had a mass in the head of pancreas with a
dilated CBD.
Overall groove pancreatitis was suggested in three
of six patients (50%), and of the three remaining
patients, two had indeterminate masses in the head of
pancreas and one had a cystic lesion in the head of
pancreas.
Nine patients underwent trans-duodenal endo-
scopic ultrasound  four had prior CT only, three
had CT and MRI, and two had MRI alone. EUS
demonstrated a combination of cystic changes in the
duodenal wall and duodenal wall thickening in four
patients and duodenal wall thickening alone in two
patients. Of the remaining three patients, one had
features of CP only, while the other two had cystic
masses in the head of pancreas. On EUS features
suggestive of CP were present in two-thirds of the
patients (67%).
Correlation of EUS findings with CT and MRI
Correlation of CT and EUS findings showed agree-
ment in five of seven cases (71%). A cystic lesion
observed within the duodenal wall on CT (in one
patient) was shown to have duodenal wall thickening
alone on EUS. Duodenal wall thickening observed on
CT was in agreement with EUS findings (one
patient); however, cystic masses seen in the head of
pancreas on CT (two patients) were thought to be in
the duodenal wall in one patient and head of pancreas
in the other. EUS provided additional information
with respect to the presence of CP (five additional
cases to the one observed on CT). EUS observations
differed from those on CT in two patients. In the first
case, CT revealed a 4 cm mass in the uncinate process
associated with mild CBD and PD dilatation, while
EUS suggested CP confined to the body and tail of
pancreas and no masses. In the second patient, CT
correctly identified inflammatory changes confined to
the pancreaticoduodenal groove, whereas EUS sug-
gested a more diffuse CP of the head of pancreas.
MRCP agreed with EUS findings in all five cases
(100%), although CP was more frequently detected
or suspected on EUS. Of the two patients in which
GP could not be diagnosed on MRI, EUS was able to
define a solid lesion on MR to be cystic lesion with
CP, and an ill-defined lesion in another patient to be
changes associated with CP.
All patients underwent a pancreaticoduodenect-
omy. One patient, with underlying restrictive airways
disease (COPD), developed postoperative adult re-
spiratory distress syndrome (ARDS) and multi-organ
failure (MOF). After a median follow-up period of
52 weeks (range 4156), all patients experienced
significant pain alleviation. Nine of the 10 patients
no longer require any analgesia, and one patient is
currently on non-opiate analgesia (Table II). At
2 months follow-up, significant weight gain (average
3 kg) was reported in all patients.
Histopathology
All cases showed active chronic inflammation of the
pancreaticoduodenal interface and adjacent duodenal
wall and pancreatic head, with extensive scarring and
widening of the pancreaticoduodenal groove (Table
II). In all cases cystic spaces were identified, which
varied in number (115) and size (0.22.0 cm). Most
of the cysts were located within the duodenal muscu-
laris propria and submucosa and/or pancreaticoduo-
denal groove, and some cavities extended into the
adjacent pancreatic parenchyma (Figure 1). The cyst
walls consisted of either granulation tissue, often with
palisaded histiocytes, or pancreatic duct-type colum-
nar epithelium. Some cysts contained foci of squa-
mous or mucinous epithelial lining.
Ectopic pancreatic tissue, including acini, islets and
ducts, was identified in the duodenal wall of all cases
(Figure 2). In one of the cases, ectopic pancreatic
tissue was also found in the wall of the gastric antrum.
The volume of the ectopic tissue varied from micro-
scopic foci to grossly visible nodular lesions in the
major and minor papilla of two cases. Intramural
ectopic pancreatic tissue was often associated with
disarray of the surrounding muscularis propria. Many
of the ectopic pancreatic ducts were dilated, and some
showed evidence of rupture and/or inflammation.
None of the above features were found below the
level of the ampulla of Vater, and in most cases,
inflammatory changes appeared more pronounced in
Figure 1. Four irregular cystic spaces measuring up to 1.5 cm in
diameter are present within the duodenal submucosa and muscu-
laris propria (arrows). The overlying duodenal (sub)mucosa (arrow-
heads) is thickened.
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the superior portion of the pancreatic head, at the
level of the minor papilla or above.
Brunner’s gland hyperplasia was seen in all cases,
and in combination with the above-described inflam-
matory changes; in seven cases this resulted in marked
thickening and irregularity of the duodenal wall,
swelling of the mucosal folds and luminal narrowing
of the duodenum over a median distance of 6 cm
(5.58 cm).
The severity of inflammation of the adjacent
pancreatic parenchyma varied markedly. Active
chronic inflammation with or without cystic alteration
extended over a median distance of 1.5 cm (0.7
2.5 cm) into the pancreatic head. In two cases, there
was inflammatory rupture of the Santorini duct with
severe inflammation and necrosis of adjacent pan-
creatic parenchyma, and in one case extension of
necrotizing inflammation into the anterior peripan-
creatic fat. In both cases, ectopic pancreatic tissue was
present in and compressed the minor papilla. In two
further cases, necrotizing inflammation extended to
within 1 mm from the main pancreatic duct.
Evidence of chronic pancreatitis, affecting the
pancreas at a distance from the pancreaticoduodenal
groove, was identified in two cases. In all other cases,
there was a varying degree of pancreatic duct dilata-
tion, with prominent intraductal protein plugs. Two
cases contained a peri-ampullary (duodenal) diverti-
culum.
Discussion
In the original report by Becker and Mischke, groove
pancreatitis was described as an inflammatory process
occurring between the C-loop of the duodenum and
head of pancreas and scarring of the pancreaticoduo-
denal groove [4]. In a topographical analysis of over
600 surgical resected cases of CP, of which 19.5% had
groove involvement, Becker and Mischke described
3 types of GP [4]: that which oc o ocurred in the
groove alone  termed ‘pure GP’ (2%), that which in
in in addition had segmental pancreatitis of head
of pancreas  termed segmental GP (6.5%), and a
chronic homogenous pancreatitis with groove involve-
ment (non-segmental GP)  (11%).
Common symptoms in all our patients were in-
tractable chronic abdominal pain, often requiring
opiate-based analgesia, along with nausea and vomit-
ing, although only 5 of 11 patients presented with
overt symptoms of gastric outlet obstruction. Duode-
nal stenosis occurs as a consequence of compression
from GP and cystic degenerative changes in the
duodenal wall [4,6,10]. It has been reported in 50
70% of cases of GP [4,6], and is less frequently
observed in CP (31%) and pancreatic cancer
(16.7%). Duodenal wall cysts are often multiple and
appear to be related to pancreatic heterotopia
[4,10,11]. Duodenal wall cysts were observed in
49% of all cases of groove scarring in Becker and
Mischke’s series [4], although only in 9% and 16% of
cases of pure GP and segmental GP, respectively, in
the series of Stolte et al. [6]. However, the incidence
of solitary cysts in the groove was much higher, 25%
in non-segmental GP, 36% in GP and 26% in
segmental GP. Duodenal wall thickening and duode-
nal wall cysts were observed on CT in 90% and 70%
of our cases, respectively [1012]. In a retrospective
series of 20 patients with GP, Vullierme et al.
described these duodenal changes in all cases,
whereby the cysts were often multiple and large
[12]. Marked Brunner’s gland hyperplasia was a
constant contributing factor to the thickening of the
duodenal wall, and a complex pathophysiological
relationship between chronic alcohol consumption,
GP and Brunner’s gland hyperplasia has been sug-
gested previously [6].
Histopathological examination of our specimens
demonstrated cystic lesions in the duodenal wall of
all cases. These were mostly multiple and varied in
size from 0.2 cm to 2 cm. Some of the cysts had
retained their epithelial lining, which was of pancrea-
tic duct type, while others showed evidence of
rupture, and were demarcated by granulation tissue
Figure 2. (A) Ectopic pancreatic tissue, composed of acini (arrow
heads) and ductules is present within the duodenal muscularis
propria. One of the ectopic ducts is cystically dilated (arrows)
(50). (B) Some of the cystic lesions (arrows) within the duodenal
wall are inflamed and have lost their epithelial lining (200).
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(so-called pseudocysts). Ectopic pancreatic tissue was
present in all our specimens, and there seemed to be
a gradual transition from small or dilated ectopic
pancreatic ducts to the above-described cysts and
pseudocysts. The ectopic pancreatic tissue and in-
flammatory changes were localized along to the
pancreaticoduodenal interface superior to the ampulla
of Vater, while the pancreas below the ampulla
remained mainly unaffected. This distribution pat-
tern, which has been described previously [5], is
intriguing and raises the possibility of a link with the
complex embryogenesis of the pancreatic head. Inter-
estingly, the ventral anlage, from which most of the
inferior (infra-papillary) part of the pancreatic head is
derived, fuses with the duodenum at a later stage than
the dorsal anlage, and it can be speculated that this is
associated with a lower incidence of pancreatic
heterotopia.
Inflammation was often not limited to the pancrea-
ticoduodenal groove and in some cases this extended
deep into the pancreatic head over a distance of up to
2.5 cm. In two cases extensive and severe inflamma-
tion of pancreatic parenchyma and peripancreatic fat
was associated with rupture of the Santorini duct. In a
further two cases, necrotizing inflammation extended
to within 1 mm of the main pancreatic duct.
Scarring of the CBD is reportedly the mechanism
which leads to stenosis of the distal CBD, with
dilatation of the proximal biliary tree [46]. Pancrea-
tic ductal dilatation is less frequent and is related to
segmental GP, and often described to be absent in
pure GP [4,6]. In segmental GP fibrosis of the
pancreatic parenchyma leads to stenosis of the PD
of Santorini, sparing the duct of Wirsung. Inflamma-
tion, atrophy and fibrosis associated small ductal
rupture in pancreatic parenchyma adjacent to the
groove was commonly observed, although pancreatic
ductal dilatation with protein plugging and intraduc-
tal calculi was observed in only three cases  deemed
segmental GP.
GP is likely a consequence of inflammation of
ectopic pancreatic tissue, the extent of which may
explain the varying clinical presentation. The pre-
sence of intractable pain and/or pancreatic insuffi-
ciency (weight loss, steatorrhoea or diabetes), can be
attributed to the severe inflammatory and fibrotic
changes observed in the head of pancreas  often
associated with duodenal obstruction secondary to
scarring or cystic dystrophy. In such patients, a
pancreaticoduodenectomy affords symptomatic relief
and can lead to adequate weight gain.
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